Loading
Total declarations
Company
▲ Purchases (4 ops.)
▼ Sales (0 ops.)
Latest filing published 30 Jun 2025 for Vivoryon Therapeutics N.V.. Read the official filing
Filing timeline
BuySaleC.P. Riedl
Insider track record
Disclosed buys
4
Disclosed sells
0
Not enough buy signals with a settled T+90 horizon to measure a track record yet.
Signal history
No signal scores available.
C.P. Riedl: trading record in brief
C.P. Riedl is a declared insider of Vivoryon Therapeutics N.V., with filings sourced from AFM. The record holds 4 filings, for trades running from 22 June 2022 to 30 June 2025.
The open-market record is one-sided, with 4 purchases and not one sale. No amount is published for 4 filings, which the totals therefore leave out. Open-market purchases are the filings investors watch most closely, because the insider pays for the shares out of pocket. 2025 to date brings 1 purchase and no sales.
On 30 June 2025 came the latest disclosure, an open-market purchase in Vivoryon Therapeutics N.V. Source: insider filings from AFM. Past trades are no guide to future returns.
Companies and markets linked to C.P. Riedl
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
Declarations4 total
25,000 shares0OptieAFM:176908
Canonical exit: 28 Sept 2025 (T+90)
25,000 shares0OptieAFM:160247
Canonical exit: 19 Sept 2024 (T+90)
90,000 shares0OptieAFM:144123
Canonical exit: 20 Sept 2022 (T+90)
1,000 shares0Gewoon aandeelAFM:145240
Canonical exit: 20 Sept 2022 (T+90)
4 of 4 declarations
